Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 104 (RN7SKP104), also known as "RNA, 7SK small nuclear pseudogene 104," refers to a **pseudogene** related to the functional 7SK small nuclear RNA (RN7SK). As a pseudogene, it is generally considered a non-functional genomic element derived from a functional gene, in this case, RN7SK[4]. **RN7SK pseudogene 104** is a pseudogene—an inactive genomic sequence that shares homology with the functional RN7SK gene, which encodes a small nuclear RNA (snRNA) involved in the regulation of transcription elongation by RNA polymerase II[4]. The active 7SK RNA functions as a scaffold in a ribonucleoprotein complex that regulates P-TEFb, thereby controlling RNA polymerase II's transition into productive elongation during transcription[1][2][5]. However, RN7SKP104 itself lacks evidence for expression or function and is not implicated as a therapeutic target, receptor, or molecule with biological, disease, or pharmacological relevance[4]. **Key clarifications:** - **Pseudogenes** like RN7SKP104 do not produce functional RNA or protein, and there is no evidence linking this specific pseudogene to any therapeutic targeting, biological process, or disease involvement[4]. - All functional and biological significance in the 7SK family is attributed to the parent gene RN7SK, not RN7SKP104[1][2][5]. RN7SKP104 should not be confused with RN7SK, an active non-coding snRNA with pivotal roles in transcription regulation and cell cycle control, which is considered biologically relevant but not a typical drug target[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 104 (RN7SKP104).